title: Borderline resectable pancreatic adenocarcinoma, is conversion therapy realistic?
authors.affiliation: Department of Medical Oncology, Mercy University Hospital , Cork , Ireland.
authors.forename: Ciara M
authors.initials: CM
authors.lastname: Kelly
authors.forename: Mazen
authors.initials: M
authors.lastname: El Bassiouni
authors.forename: Michael W
authors.initials: MW
authors.lastname: Bennett
authors.forename: Lee
authors.initials: L
authors.lastname: Crush
authors.forename: Peter
authors.initials: P
authors.lastname: McEneaney
authors.forename: Criostoir
authors.initials: C
authors.lastname: O'Suilleabhain
authors.forename: Derek G
authors.initials: DG
authors.lastname: Power
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology* / Q000628:therapy*; D059248:Chemoradiotherapy / Q000379:methods; D003131:Combined Modality Therapy / Q000379:methods; D005260:Female; D006801:Humans; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000473:pathology* / Q000628:therapy*; D016577:Pancreaticoduodenectomy / Q000379:methods